Laurus Labs joins Dow Jones Best-in-Class Indices

1 min read     Updated on 21 May 2026, 07:52 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Laurus Labs has been included in the Dow Jones Best-in-Class (DJ BIC) World Index for the first time. The company achieved an S&P Global CSA score of 81 out of 100, up from 71 in the previous year. This inclusion reinforces the company's credibility with global investors and highlights its commitment to sustainable practices.

powered bylight_fuzz_icon
40918937

*this image is generated using AI for illustrative purposes only.

Laurus Labs has been included in the Dow Jones Best-in-Class (DJ BIC) World Index for the first time. This inclusion highlights the company's commitment to sustainable and ethical corporate governance practices. The DJBIC World Index ranks top-performing companies globally with strong ESG performance.

The company was previously featured in the S&P Global Sustainability Yearbook 2026, which ranks the world's most sustainable companies. Laurus Labs achieved an S&P Global Corporate Sustainability Assessment (CSA) score of 81 out of 100 in the category of pharmaceutical companies, an improvement from the previous year's score of 71 out of 100.

The Dow Jones Best-in-Class Indices identify and recognize companies that demonstrate exceptional performance across key Environmental, Social, and Governance (ESG) parameters. This recognition is based on leading S&P Global CSA scores.

Inclusion in DJ BIC indices reinforces Laurus Labs's credibility with global investors. It places the company among a distinguished group of global leaders recognized for best-in-class sustainability performance.

Metric Score
S&P Global CSA Score (Current Year) 81 out of 100
S&P Global CSA Score (Previous Year) 71 out of 100
Category Pharmaceutical Companies

This milestone reflects the dedication of the team at Laurus Labs to its core values of science-driven, responsible, and sustainable business practices.

Historical Stock Returns for Laurus Labs

1 Day5 Days1 Month6 Months1 Year5 Years
-0.74%+5.51%+19.61%+36.87%+127.73%+180.49%

How might Laurus Labs' inclusion in the DJ BIC World Index influence its ability to attract ESG-focused institutional investors and impact its stock valuation in the near term?

Could Laurus Labs' improved CSA score of 81 open doors to preferential financing or green bonds, and how might this affect its capital structure going forward?

What specific ESG initiatives is Laurus Labs likely to prioritize to maintain or further improve its sustainability ranking in the next S&P Global CSA assessment?

Laurus Labs Records ₹18.67 Crore Block Trade on NSE at ₹1354.80 Per Share

0 min read     Updated on 20 May 2026, 12:56 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Laurus Labs recorded a block trade on the NSE involving approximately 137,809 shares at ₹1354.80 per share. The total value of the transaction stood at ₹18.67 crores. Such block trades are generally indicative of large-scale institutional participation in the stock.

powered bylight_fuzz_icon
40807588

*this image is generated using AI for illustrative purposes only.

Laurus Labs witnessed a notable block trade on the National Stock Exchange (NSE), with approximately 137,809 shares transacted in a single deal. The trade was executed at a price of ₹1354.80 per share, aggregating to a total transaction value of ₹18.67 crores.

Block Trade Details

The following table summarises the key parameters of the block trade recorded on the NSE:

Parameter: Details
Exchange: NSE
Number of Shares: ~137,809
Trade Price: ₹1354.80 per share
Total Trade Value: ₹18.67 crores

Block trades of this scale are typically associated with large institutional investors or significant stakeholders executing bulk transactions outside the regular market order book. The trade in Laurus Labs reflects considerable activity at the institutional level in the stock.

Historical Stock Returns for Laurus Labs

1 Day5 Days1 Month6 Months1 Year5 Years
-0.74%+5.51%+19.61%+36.87%+127.73%+180.49%

Which institutional investor executed this block trade, and does it signal a strategic accumulation or exit from Laurus Labs?

How might this large institutional transaction influence Laurus Labs' stock price trajectory and retail investor sentiment in the near term?

Are there any upcoming catalysts, such as quarterly earnings or new drug approvals, that could have motivated this block trade timing?

More News on Laurus Labs

1 Year Returns:+127.73%